cysteine proteinase inhibitors

Preferred Label : cysteine proteinase inhibitors;

MeSH definition : Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES.;

MeSH synonym : proteinase inhibitors, cysteine; protease inhibitors, cysteine; cysteine proteinase antagonists; inhibitors, cysteine proteinase; cysteine protease inhibitors; inhibitors, cysteine protease; antagonists, cysteine proteinase; proteinase antagonists, cysteine; Cysteine Proteinase Inhibitor; Inhibitor, Cysteine Proteinase; Proteinase Inhibitor, Cysteine; Cysteine Protease Inhibitor; Inhibitor, Cysteine Protease; Protease Inhibitor, Cysteine; Cysteine Proteinase Antagonist; Antagonist, Cysteine Proteinase; Proteinase Antagonist, Cysteine;

MeSH hyponym : acid cysteine proteinase inhibitors; cysteine proteinase inhibitors, endogenous; alpha-Cysteine protease inhibitors; cysteine proteinase inhibitors, exogenous; Inhibitors, alpha-Cysteine Protease; Protease Inhibitors, alpha-Cysteine; alpha Cysteine Protease Inhibitors; alpha-Cysteine Protease Inhibitor; Inhibitor, alpha-Cysteine Protease; Protease Inhibitor, alpha-Cysteine; alpha Cysteine Protease Inhibitor; Acid Cysteine Proteinase Inhibitor;

CISMeF hyponym : Inhibiteurs de l'acid cysteine proteinase;

MeSH annotation : /biosyn /physiol permitted only with endogenous proteinase inhib; DF: CYSTEINE PROTEINASE INHIB;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D015853;

UMLS CUI

C0010658;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Cysteine Proteinase Inhibitor Gene [NCIt concept]
Indexing information
- N-methylpiperazine-urea-arginyl-homophenylalanyl-vinylsulfonebenzene [MeSH Supplementary Concept]
- interleukin-1beta-converting enzyme inhibitor [MeSH Supplementary Concept]
- ovocystatin [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- cysteine endopeptidases [MeSH Descriptor]
- cysteine proteases [MeSH Descriptor]
Record concept(s)
- acid cysteine proteinase inhibitors [MeSH concept]
- alpha-Cysteine protease inhibitors [MeSH concept]
- cysteine proteinase inhibitors [MeSH concept]
- cysteine proteinase inhibitors, endogenous [MeSH concept]
- cysteine proteinase inhibitors, exogenous [MeSH concept]
See also (suggested by CISMeF)
- cysteine endopeptidases [MeSH Descriptor]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1,3-bis(acylamino)-2-butanone [MeSH Supplementary Concept]
- 4-hydroxy-2-nonenal [MeSH Supplementary Concept]
- BIRC5 protein, human [MeSH Supplementary Concept]
- E 64 [MeSH Supplementary Concept]
- L 709049 [MeSH Supplementary Concept]
- MDL 201053 [MeSH Supplementary Concept]
- N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline [MeSH Supplementary Concept]
- N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone [MeSH Supplementary Concept]
- SF 324 [MeSH Supplementary Concept]
- ac-aspartyl-glutamyl-valyl-aspartyl-aminomethylcoumarin [MeSH Supplementary Concept]
- acetyl-aspartyl-glutamyl-valyl-aspartal [MeSH Supplementary Concept]
- acetylleucyl-leucyl-norleucinal [MeSH Supplementary Concept]
- aloxistatin [MeSH Supplementary Concept]
- aspartyl-glutamyl-valyl-aspartal [MeSH Supplementary Concept]
- benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone [MeSH Supplementary Concept]
- benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal [MeSH Supplementary Concept]
- benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone [MeSH Supplementary Concept]
- benzyloxycarbonylleucyl-leucyl-leucine aldehyde [MeSH Supplementary Concept]
- benzyloxycarbonylphenylalanylalanine diazomethyl ketone [MeSH Supplementary Concept]
- calpain inhibitor 2 [MeSH Supplementary Concept]
- calpain inhibitor III [MeSH Supplementary Concept]
- calpain inhibitors [MeSH Supplementary Concept]
- calpastatin [MeSH Supplementary Concept]
- calpeptin [MeSH Supplementary Concept]
- clasto-lactacystin beta-lactone [MeSH Supplementary Concept]
- cystatin B [MeSH Descriptor]
- cystatin, egg-white [MeSH Supplementary Concept]
- cystatins [MeSH Descriptor]
- geldanamycin [MeSH Supplementary Concept]
- inhibitor of apoptosis, nucleopolyhedrovirus [MeSH Supplementary Concept]
- kininogens [MeSH Descriptor]
- lactacystin [MeSH Supplementary Concept]
- leupeptin [MeSH Supplementary Concept]
- nitroaspirin [MeSH Supplementary Concept]
- pentenocin A [MeSH Supplementary Concept]
- pentenocin B [MeSH Supplementary Concept]
- phenylalanyl-prolyl-arginine-chloromethyl ketone [MeSH Supplementary Concept]
- salivary cystatins [MeSH Descriptor]
- succinyl-alanyl-valyl-valyl-alanyl-psi(CH2NH)-alanyl-4-nitroanilide [MeSH Supplementary Concept]
- succinyl-alanyl-valyl-valyl-psi(CH2NH)-alanyl-alanyl-4-nitroanilide [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients